Global Intracranial Pressure (ICP) Monitoring Market Information – Global Forecast Till 2024

$4,450$6,250

Global Intracranial Pressure (ICP) Monitoring Market Information: by Route of Intervention (Intraventricular, Epidural Sensor), Technique (Invasive, Non-invasive), Application (Traumatic Brain Injury, Subarachnoid Hemorrhage), Device (Intraventricular Catheter, Epidural Sensors), End-user (Hospitals & Clinics), and Region – Global Forecast Till 2024

Clear
SKU: 190637 Categories: , Tag:

Description

Introduction
Intracranial pressure (ICP) is the pressure which develops first on the skull and eventually in the brain tissue and cerebrospinal fluid (CSF). ICP results in intracranial hypertension eventually. Therefore, ICP needs monitoring to treat severe traumatic brain injury patients. The growing prevalence of neurovascular diseases such as brain aneurysm and arteriovenous malformations (AVMs), favorable reimbursement policies, increasing prevalence of traumatic injuries, and ongoing product developments and commercialization are expected to drive the market growth. According to a study published in the Methodist DeBakey Cardiovascular Journal in 2014, about one million strokes occur annually in the US with 10 to 15% accounting for the intracranial atherosclerotic disease. However, a shortage of trained professionals and high procedural cost of ICP monitoring devices may hamper the growth of the market.
The global intracranial pressure (ICP) monitoring market is expected to reach a market value of USD 2,013.9 million by 2024 from USD 1,160.1 million in 2016 and is expected to register a CAGR of 7.1% during the forecast period from 2016 to 2024. In 2016, the Americas held the highest share of the market at 41.4%, followed by Europe and Asia-Pacific with shares of 33.4% and 20.5%, respectively. Growing technological advancements worldwide are expected to increase the growth of the market during the forecast period.
The global intracranial pressure (ICP) monitoring market is segmented into route of intervention, technique, application, device, end user, and region.
The global intracranial pressure (ICP) monitoring market, by route of intervention, is segmented into intraventricular, epidural sensors, and others.
The global intracranial pressure (ICP) monitoring market, by technique, is segmented into invasive and non-invasive. Invasive techniques are further segmented into external ventricular drainage (EVD) and microtransducer ICP monitoring. Non-invasive techniques are further segmented into transcranial Doppler ultrasonography, tympanic membrane displacement (TMD) analyzer, optic nerve sheath diameter sonography, MRI/CT, and fundoscopy (papilledema).
The global intracranial pressure (ICP) monitoring market, by application, is segmented into traumatic brain injury, intracerebral hemorrhage, meningitis, subarachnoid hemorrhage, and others.
The global intracranial pressure (ICP) monitoring market, by device, is segmented into intraventricular catheters, subarachnoid screws, epidural sensors, non-invasive ICP monitors, and others.
By end user, the global intracranial pressure (ICP) monitoring market is segmented into hospitals and clinics, trauma centers, and others.
Key Players
Integra LifeSciences Corporation, DePuy Synthes, Spiegelberg GmbH & Co. KG, RAUMEDIC Inc, Sophysa SA, Boston Neurosciences, Medtronic Plc, Terumo Corporation, and Natus Medical Incorporated
Study Objectives
• To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the intracranial pressure (ICP) monitoring market
• To provide insights into factors affecting the market growth
• To analyze the global intracranial pressure (ICP) monitoring market based on various tools such as supply chain analysis and Porter’s five force analysis
• To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries
• To provide country-level analysis of the market with respect to the current market size and future perspective
• To provide country-level analysis of the market for segments by route of intervention, technique, application, device, end user, and region
• To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the intracranial pressure (ICP) monitoring market
Target Audience
• Brain Monitoring Device Manufacturers & Suppliers
• Contract Research Organizations (CROs)
• Research and Development (R&D) Companies
• Government Research Laboratories
Key Findings
• The global intracranial pressure (ICP) monitoring market is expected to reach USD 2,013.9 million by 2024 at a CAGR of 7.1% from 2016 to 2024
• On the basis of route of intervention, the intraventricular segment accounted for the largest market share at a CAGR of 7.4%
• On the basis of technique, the invasive technique segment accounted for the largest market share at a CAGR of 7.1%
• On the basis of application, traumatic brain injury segment accounted for the largest market share at a CAGR of 7.5%
• On the basis of devices, the intraventricular catheter segment accounted for the largest market share at a CAGR of 7.4%
• On the basis of end user, the hospitals and clinics segment accounted for the largest market share at a CAGR of 7.4%
• The Americas is expected to hold the largest share of the global intracranial pressure (ICP) monitoring market at a CAGR of 7.3% by 2024
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 7.4% by 2024
Regional Analysis
• Americas
o North America
 US
 Canada
o South America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa

Table of Contents

Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 List of Assumptions
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing prevalence of neurovascular diseases such as brain aneurysm, Arteriovenous Malformations (AVMs), and others, are likely to propel the ICP monitoring market
4.2.2 Favourable reimbursement policies provide favourable background for the market growth
4.2.3 Growing prevalence of traumatic brain injuries
4.2.4 Ongoing product development & commercialization will boost the ICP monitoring market
4.3 Restraints
4.3.1 The shortage of trained professionals
4.3.2 High procedural cost of ICP monitoring devices
4.4 Opportunities
4.4.1 Increasing use of endovascular embolization for the treatment of brain aneurysm
4.5 Macroeconomic indicators
5 Market factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D & Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Review
5.2 Porter’s Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Re-Operation Rate Analysis
5.4 Complication Rate Analysis
6 Global Intracranial Pressure (ICP) Monitoring Market, By Route of Intervention
6.1 Introduction
6.2 Intraventricular
6.3 Epidural Sensor
7 Global Intracranial Pressure (ICP) Monitoring Market, By Technique
7.1 Introduction
7.2 Invasive
7.3 Non-invasive
7.3.1 Transcranial Doppler Ultrasonography
7.3.2 Tympanic Membrane Displacement (TMD) Analyzer
7.3.3 Optic Nerve Sheath Diameter Sonography
7.3.4 Fundoscopy (Papilledema)
7.3.5 MRI/CT
8 Global Intracranial Pressure (ICP) Monitoring Market, By Application
8.1 Introduction
8.2 Traumatic Brain Injury
8.3 Intracerebral Hemorrhage
8.4 Subarachnoid Hemorrhage
8.5 Meningitis
9 Global Intracranial Pressure (ICP) Monitoring Market, By Device
9.1 Introduction
9.2 Intraventricular catheter
9.3 Subarachnoid screw
9.4 Non-invasive ICP monitors
9.5 Epidural sensors
10 Global Intracranial Pressure (ICP) Monitoring Market, By End User
10.1 Introduction
10.2 Hospitals & Clinic
10.3 Trauma centers
11 Global Intracranial Pressure (ICP) Monitoring Market: by Region
11.1 Introduction
11.2 Americas
11.2.1 North America
11.2.1.1 U.S
11.2.1.2 Canada
11.2.2 South America
11.3 Europe
11.3.1 Western Europe
11.3.1.1 Germany
11.3.1.2 France
11.3.1.3 U.K
11.3.1.4 Italy
11.3.1.5 Spain
11.3.1.6 Rest of Western Europe
11.3.2 Eastern Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 Rest of Asia Pacific
11.5 Middle East & Africa
11.5.1 Middle East
11.5.2 Africa
11.5.3 Rest of Middle East & Africa
12 Competitive Landscape
12.1 Company Market Share Analysis
12.1.1 Introduction
12.2 Competitive Landscape
12.2.1 Introduction
12.3 Key Developments
13 Company Profiles
13.1 Integra LifeSciences Corporation
13.1.1 Company Overview
13.1.2 Financial Overview
13.1.3 Products Offering
13.1.4 Key Developments
13.1.5 SWOT Analysis
13.1.6 Key Strategy
13.2 DePuy Synthes
13.2.1 Company Overview
13.2.2 Financial Overview
13.2.3 Products Offering
13.2.4 Key Developments
13.2.5 SWOT Analysis
13.2.6 Key Strategy
13.3 Spiegelberg GmbH & Co. KG
13.3.1 Company Overview
13.3.2 Financial Overview
13.3.3 Products Offering
13.3.4 Key Developments
13.3.5 SWOT Analysis
13.3.6 Key Strategy
13.4 RAUMEDIC Inc
13.4.1 Company Overview
13.4.2 Financial Overview
13.4.3 Products Offering
13.4.4 Key Developments
13.4.5 SWOT Analysis
13.4.6 Key Strategy
13.5 Sophysa SA
13.5.1 Company Overview
13.5.2 Financial Overview
13.5.3 Products Offering
13.5.4 Key Developments
13.5.5 SWOT Analysis
13.5.6 Key Strategy
13.6 Boston Neurosciences
13.6.1 Company Overview
13.6.2 Financial Overview
13.6.3 Products Offering
13.6.4 Key Developments
13.6.5 SWOT Analysis
13.6.6 Key Strategy
13.7 Medtronic Plc
13.7.1 Company Overview
13.7.2 Financial Overview
13.7.3 Products Offering
13.7.4 Key Developments
13.7.5 SWOT Analysis
13.7.6 Key Strategy
13.8 Terumo Corporation
13.8.1 Company Overview
13.8.2 Financial Overview
13.8.3 Products Offering
13.8.4 Key Developments
13.8.5 SWOT Analysis
13.8.6 Key Strategy
13.9 Natus Medical Incorporated
13.9.1 Company Overview
13.9.2 Financial Overview
13.9.3 Products Offering
13.9.4 Key Developments
13.9.5 SWOT Analysis
13.9.6 Key Strategy
14 Appendix
14.1 Discussion Blue Print

Additional information

Publisher

Geography Covered

Date Published

Pages

Format